Skip to content

Anxiety: all studies

Page 521 of 773: studies 5,201 to 5,210 of 7,721, newest first. Back to the anxiety overview

Research

Mindfulness-Based Interventions for Survivors of Lung Cancer and Their Partners: A Systematic Review.

International Journal of Behavioral Medicine October 2023 Karen Kane McDonnell, Otis L Owens, Fattona Umari

Survivors of lung cancer and their partners often have complex unresolved physical, psychosocial, and behavioral needs that can negatively affect the survivors' and partners' well-being. This systematic review aimed to (1) examine the content and delivery of mindfulness-based interventions (MBIs) and (2) summarize and synthesize the current evidence for effectiveness of MBIs targeting survivors...

DOI: 10.1007/s12529-022-10132-3 (opens in new tab) Full text (opens in new tab) Dyads Lung neoplasm Mindfulness-based interventions Systematic review

PPARα and PPARγ are expressed in midbrain dopamine neurons and modulate dopamine- and cannabinoid-mediated behavior in mice.

Molecular Psychiatry October 2023 Briana J. Hempel, Madeline Crissman, Sruti Pari et al.

Peroxisome proliferator-activated receptors (PPARs) are a family of nuclear receptors that regulate gene expression. Δ9-tetrahydrocannabinol (Δ9-THC) is a PPARγ agonist and some endocannabinoids are natural activators of PPARα and PPARγ. However, little is known regarding their cellular distributions in the brain and functional roles in cannabinoid action. Here, we first used RNAscope in situ...

FABP5 is important for cognitive function and is an important regulator of the physiological effects and pharmacokinetics of acute Δ9 tetrahydrocannabinol inhalation in mice.

Pharmacology, Biochemistry, and Behavior October 2023 Samantha L Penman, Nicole M Roeder, Erin C. Berthold et al.

Fatty acid binding protein 5 (FABP5) interacts with the endocannabinoid system in the brain via intracellular transport of anandamide, as well as Δ9-tetrahydrocannabinol (THC), the main psychoactive component of cannabis. Previous work has established the behavioral effects of genetic deletion of FABP5, but not in the presence of THC. The present study sought to further elucidate the role of...

DOI: 10.1016/j.pbb.2023.173633 (opens in new tab) Full text (opens in new tab) Endocannabinoid system Locomotion Memory Pharmacokinetics +1

Influence of the dose of ketamine used on schizophrenia-like symptoms in mice: A correlation study with TH, GAD67, and PPAR-γ.

Pharmacology, Biochemistry, and Behavior October 1, 2023 Talita Rodrigues, Getulio Nicola Bressan, Barbara Krum et al.

Schizophrenia is a chronic, debilitating mental illness that has not yet been completely understood. In this study, we aimed to investigate the effects of different doses of ketamine, a non-competitive NMDA receptor antagonist, on the positive- and negative-like symptoms of schizophrenia. We also explored whether these effects are related to changes in the immunoreactivity of GAD67, TH, and...

Effect of Vibhaga pranayama on cardiopulmonary functions in healthy individuals

Journal of Integrative Medicine and Research October 1, 2023 A. Vijay, S. Suganthi, P. Deebika et al.

Background: Lifestyle changes play a major role in the treatment, prevention, and rehabilitation of cardiopulmonary disorders. Vibhaga pranayama in combination with other pranayamas has been shown to improve pulmonary function. However, no published study has explored the effects of only Vibhaga pranayama on cardiopulmonary functions either in healthy or in pathological conditions....

Reliability and validity of the Chinese version of the Nightmare disorder index in adolescents.

Stress and Health October 1, 2023 Yun‐Yue Zhuang, Lei-Lei Wang, Tian‐He Song et al.

The Nightmare Disorder Index Questionnaire (NDI) was developed to measure the impact of nightmares. The purpose of this study was to investigate the psychometric properties of NDI among Chinese adolescents. This study investigated the validity and internal consistency of the Nightmare Disorder Index Chinese (NDI-CV) among 6014 Chinese adolescents who completed the NDI-CV, Nightmare Distress...

Pharmacists and psychedelic medicine

JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY October 1, 2023 Kelan Thomas

In coming years, pharmacists will begin fielding more questions regarding psychedelic medicine, most notably with the imminent FDA approval of 3,4-methylenedioxymethamphetamine (MDMA) for posttraumatic stress disorder (PTSD) expected in 2024 and psilocybin for major depressive disorder (MDD) likely in 2025. Psychedelics are unique medications in many ways, but especially due to the mental...

Mindfulness-based cognitive therapy v. treatment as usual in people with bipolar disorder: A multicentre, randomised controlled trial.

Psychological Medicine October 1, 2023 Imke Hanssen, Marloes J. Huijbers, Eline Regeer et al. 7 citations

Mindfulness-based cognitive therapy (MBCT) seems a promising intervention for bipolar disorder (BD), but there is a lack of randomised controlled trials (RCT) investigating this. The purpose of this multicentre, evaluator blinded RCT was to investigate the added value of MBCT to treatment as usual (TAU) in BD up to 15 months follow-up (NCT03507647). A total of 144 participants with BD type I...

DOI: 10.1017/S0033291723000090 (opens in new tab) Full text (opens in new tab) Mindfulness-based cognitive therapy Bipolar disorder Effectiveness Randomised controlled trial

Near-death experiences are associated with rapid eye movement (REM) sleep intrusions in migraine patients, independent of migraine aura.

European Journal of Neurology October 1, 2023 Bianca Raffaelli, Pia Kull, Jasper Mecklenburg et al. 6 citations

Migraine aura, near-death experiences (NDEs), and rapid eye movement (REM) sleep intrusions might share common mechanisms. Here, we investigated the prevalence of NDEs and REM sleep intrusions in people with migraine. We hypothesized that NDEs and REM sleep intrusions are more prevalent in migraine patients with aura than in those without. We conducted a prospective cross-sectional cohort study...

Impact of a Stress Reduction, Meditation, and Mindfulness Program in Patients with Chronic Heart Failure: A Randomized Controlled Trial.

Arquivos brasileiros de cardiologia October 1, 2023 Vaisnava Nogueira Cavalcante, Evandro Tinoco Mesquita, Ana Carla Dantas Cavalcanti et al. 9 citations

Heart Failure is a significant public health problem leading to a high burden of physical and psychological symptoms despite optimized therapy. To evaluate primarily the impact of a Stress Reduction, Meditation, and Mindfulness Program on stress reduction of patients with Heart Failure. A randomized and controlled clinical trial assessed the effect of a stress reduction program compared to...